Close Menu

Waters

Bruker this week launched its new Autoflex Speed MALDI TOF/TOF mass spectrometer.

Waters this week introduced its new Acquity UPLC M-Class system, a nano- to microscale UPLC system rated for 15,000 psi operation.

NEW YORK (GenomeWeb News) – Waters today reported an 8 percent spike year over year in its fourth quarter revenues as the firm beat the average Wall Street analyst estimates on the top and bottom lines.

Several major mass spec vendors took the stage this week at the JP Morgan Healthcare Conference in San Francisco, highlighting strong sales of recent instrument launches and sketching out potential future directions for their businesses.

Researchers at the Johannes Gutenberg University Mainz have devised a data-independent acquisition mass spec method that uses ion mobility drift times to improve precursor fragmentation efficiency and, consequently, protein identifications.

Agilent this week awarded Chinese Academy of Sciences researcher Junying Yuan an Agilent Thought Leader award in recognition of her research in cellular biology and neurodegenerative diseases.

NEW YORK (GenomeWeb News) – Goldman Sachs on Monday upgraded shares of Danaher's stock, while it downgraded Waters' shares.

The $11 billion in stimulus funding provided earlier this year could be just the first step of a planned major overhaul of how life science research in Japan is funded, changes that include the creation of a Japanese NIH. But some are questioning if the proposals can have a meaningful impact.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the third quarter were up 2 percent year over year, with weak pharma sales countering improved government and academic demand.

NEW YORK (GenomeWeb News) – Investment firm Mizuho today downgraded Waters, citing "choppiness around the pharmaceutical market" that may cause the company's stock to "languish."

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.